Connor, Clark & Lunn Investment Management (CC&L)’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $5.94M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $882K | Sell |
|
|||||
|
2022
Q3 | $1.68M | Sell |
|
|||||
|
2022
Q2 | $1.49M | Sell |
|
|||||
|
2022
Q1 | $1.94M | Sell |
|
|||||
|
2021
Q4 | $3.06M | Buy |
|
|||||
|
2021
Q3 | $2.38M | Buy |
|
|||||
|
2021
Q2 | $2.08M | Buy |
|
|||||
|
2021
Q1 | $1.69M | Buy |
|
|||||
|
2020
Q4 | $1.63M | Sell |
|
|||||
|
2020
Q3 | $1.29M | Sell |
|
|||||
|
2020
Q2 | $2.39M | Sell |
|
|||||
|
2020
Q1 | $1.54M | Buy |
|
|||||
|
2019
Q4 | $1.47M | Buy |
|